Atlas Trials

The Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon Gene Polymorphisms to Donepezil in Alzheimer's Disease

Clinical trial NCT00381381 · COMPLETED

Trial details

NCT number
NCT00381381
Sponsor
Eisai Korea Inc.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Alzheimer's Disease
Start date
2006-05-31
Primary completion
2008-08-31
Enrollment
199

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.